Cargando…
Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial
PURPOSE: Impaired ocular blood flow is an important risk factor in the pathogenesis of open-angle glaucoma (OAG). Studies have reported that dorzolamide 2% may be effective in improving ocular blood flow (OBF) in OAG patients. The objective of this study was to determine the efficacy of dorzolamide...
Autores principales: | Nivean, Pratheeba D, Ariga, Murali, Chithra, M R, Gohil, Pooja, Das, Sandhya, Jaideep, Gogtay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940594/ https://www.ncbi.nlm.nih.gov/pubmed/36453306 http://dx.doi.org/10.4103/ijo.IJO_1055_22 |
Ejemplares similares
-
Response to comments on: Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial
por: Ariga, Murali, et al.
Publicado: (2023) -
Correlation between choroidal thickness and intraocular pressure control in primary angle-closure glaucoma
por: Singh, Nishtha, et al.
Publicado: (2022) -
Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial
por: Srikanth, Krishnagopal, et al.
Publicado: (2023) -
Efficacy and safety of ultrasound cycloplasty in Indian eyes with open-angle glaucoma
por: Paul, Chandrima, et al.
Publicado: (2022) -
Dynamic Scheimpflug Ocular Biomechanical Parameters in Untreated Primary Open Angle Glaucoma Eyes
por: Miki, Atsuya, et al.
Publicado: (2020)